Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance

Blood markers of endothelial activation (sVCAM-1, vWF: Ag) in patients with chronic hepatitis C in the presence of insulin resistance, metabolic syndrome and its components had been evaluated. The study included 69 patients with chronic hepatitis C with oligosymptomatic the disease. In one third of...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. V. Antonova, M. A. Romanova, Yu. V. Lymar
Format:	Article
Language:	Russian
Published:	Journal Infectology 2014-09-01
Series:	Журнал инфектологии
Subjects:	chronic hepatitis c insulin resistance vascular cellular adhesion molecule-1 von willebrand factor
Online Access:	https://journal.niidi.ru/jofin/article/view/132
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Value of vWF-related indicators in the diagnosis of liver cirrhosis progression in patients with hepatitis B
by: YANG Mingkang, LIU Yu, XU Guanqun, WANG Jianbiao, WANG Xuefeng, LIANG Qian
Published: (2024-12-01)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023-05-01)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01)

von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Genetic analysis using long-read sequencing to overcome the difficulties in VWF gene
by: Sheng Ye, et al.
Published: (2025-05-01)

Comparative evaluation of anticoagulation therapy effect on coagulation and aggregation hemostasis of patients with Q-wave myocardial infarction after thrombolysis
by: V. D. Syvolap, et al.
Published: (2014-10-01)

Peculiarities of hemostasis changes under the influence of different regimens of antiplatelet therapy in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2014-12-01)

Effect of Jiawei Fuzi Lizhong decoction on Cys C,T lymphocyte subsets and vWF of patients with acute drug-induced renal damage
by: LAN Fang, et al.
Published: (2017-01-01)

Effects of Nigella sativa on VCAM-1 and ICAM-1: A systematic review of preclinical and clinical studies
by: Zeinab Faghfoori, et al.
Published: (2025-03-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

Clinical significance of ICAM-1,VCAM-1 and PECAM-1 in vascular endothelial injury of end-stage renal disease patients
by: Wang Lan-min, et al.
Published: (2021-01-01)

The relationship between serum IL⁃33，vWF，G⁃CSF and prognosis of acute massive hemorrhage patients with transfusion⁃related acute lung injury
by: DU Dan*，WEI Ge，WANG Lingxue，LIU Hongbin
Published: (2025-08-01)

The functional state of endothelium at chronic hepatitis C
by: I. A. Bulatova, et al.
Published: (2009-06-01)

Flaxseed Prevents Leukocyte and Platelet Adhesion to Endothelial Cells in Experimental Atherosclerosis by Reducing sVCAM-1 and vWF
by: Raluca Ecaterina Haliga, et al.
Published: (2013-01-01)

Intraindividual variability of von Willebrand factor and the need for repeated testing
by: Malene Helligsø Kirkeby, et al.
Published: (2025-05-01)

VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis
by: Alexandros Makis, et al.
Published: (2017-01-01)

Gender and age peculiarities of content changes of protein C, von Willebrand factor, vascular cell adhesion molecules sVCAM-1 in patients with acute left ventricle Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2015-04-01)

Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01)

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease – WIL-31 study post hoc analysis
by: Robert F. Sidonio, Jr., et al.
Published: (2025-02-01)

Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
by: Eric Manderstedt, et al.
Published: (2025-05-01)

Endothelial molecule levels (VCAM-1, ICAM-1) in uncomplicated malaria cases in Lagos, Nigeria
by: Uche T. Igbasi, et al.
Published: (2024-12-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms
by: A. V. Vorobеv, et al.
Published: (2025-05-01)

Impact of endurance training and Citrus aurantium L.var. amara Engl. (CAVAO) consumption on lipid profile, intercellular adhesion molecules-1 (ICAM-1) and vascular cell adhesion molecules-1 (VCAM-1) in aged Sprague-Dawley rats
by: Nasrin Rabiei Dargah, et al.
Published: (2023-12-01)

Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
by: Allaura A. Cox, et al.
Published: (2025-05-01)

Dynamics of endothelial function violation in patients with arterial hypertension with moderate cardiovascular risk and antihypertensive therapy treatment influence
by: T. S. Turlyun
Published: (2016-08-01)

PROGNOSTIC SIGNIFICANCE OF ENDOTHELIAL DYSFUNCTION MARKERS IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2018-05-01)

Relation of smoking and endothelial dysfunction markers in systemic hypertension
by: V. I. Podzolkov, et al.
Published: (2018-10-01)

Clinical significance of diagnostic algorithm in detection of mild hemostasis disorders in women with menorrhagia
by: Đukić Svetlana M., et al.
Published: (2020-01-01)

Bacterial pathogens under high-tension: Staphylococcus aureus adhesion to von Willebrand factor is activated by force
by: Felipe Viela, et al.
Published: (2019-06-01)

Endothelial cells expressing CPE and vWF are involved in the Immunopathogenesis of primary biliary cholangitis
by: Lin-Xiang Huang, et al.
Published: (2025-07-01)

Arterial stiffness and endothelial function in the long-term period after a coronavirus disease 2019
by: S. A. Bondar, et al.
Published: (2024-06-01)

ADAM and ADAMTS Proteases in Hepatic Disorders
by: Dirk Schmidt-Arras, et al.
Published: (2019-02-01)

Endothelial dysfunction in patients with obesity and type 2 diabetes mellitus or normoglycemia: assessment of specific markers
by: E. V. Pokrovskaya, et al.
Published: (2023-11-01)

COMBINATION OF THE ULCERATIVE COLITIS AND VON WILLEBRAND DISEASE (A CASE REPORT)
by: I. A. Grishechkina, et al.
Published: (2017-08-01)

Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
by: Inês Guerra de Melo, et al.
Published: (2024-12-01)

A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
by: Benjamin Reardon, et al.
Published: (2025-07-01)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021-11-01)

Weibel-Palade bodies – secretory organelles at the interface of inflammation and hemostasis
by: Julian Terglane, et al.
Published: (2025-06-01)